Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disease gene identification: ethical considerations.

N S Wexler1

  • 1Department of Neurology, Columbia University College of Physicians and Surgeons.

Hospital Practice (Office Ed.)
|October 15, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: Counseling implications.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics·2008
Same author

Factors associated with HD CAG repeat instability in Huntington disease.

Journal of medical genetics·2007
Same author

Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.

Journal of medical genetics·2006
Same author

Analysis of germline mutation spectra at the Huntington's disease locus supports a mitotic mutation mechanism.

Human molecular genetics·1999
Same author

John Jacob Wasmuth (1946-1995).

Nature genetics·1996
Same author

Single sperm analysis of the trinucleotide repeats in the Huntington's disease gene: quantification of the mutation frequency spectrum.

Human molecular genetics·1995
Same journal

Oral contraceptives: an update.

Hospital practice (Office ed.)·1995
Same journal

Progress in the immunogenetics of rheumatoid arthritis.

Hospital practice (Office ed.)·1995
Same journal

An asymptomatic lung nodule in an elderly woman with joint pain.

Hospital practice (Office ed.)·1995
Same journal

Defusing status epilepticus.

Hospital practice (Office ed.)·1995
Same journal

Persistent fever and flank discomfort in a young woman.

Hospital practice (Office ed.)·1995
Same journal

New thoughts on attention-deficit/hyperactivity disorder.

Hospital practice (Office ed.)·1995
See all related articles

Genetic testing for fatal autosomal diseases like cystic fibrosis and Huntington's disease requires careful consideration of privacy and the psychological impact of results. Balancing the desire for knowledge with potential distress is crucial for ethical implementation.

Area of Science:

  • Medical Genetics
  • Bioethics
  • Genetic Counseling

Background:

  • Genetic testing offers predictive information for inherited diseases.
  • Ethical considerations include data privacy, access to results, and psychological impact.
  • Autosomal diseases like cystic fibrosis (CF) and Huntington's disease (HD) present unique challenges.

Purpose of the Study:

  • To explore the ethical implications of genetic testing and screening.
  • To examine how to provide adequate protection for genetic information.
  • To discuss access to genetic testing results and the balance between knowing and potential harm.

Main Methods:

  • Case study analysis of cystic fibrosis (gene known).
  • Case study analysis of Huntington's disease (gene unknown).

Related Experiment Videos

  • Ethical framework discussion based on clinical experience.

    • Main Results:

    • The known gene status in CF allows for carrier screening but raises different ethical questions than HD.
    • The unknown gene status in HD necessitates careful genetic counseling regarding predictive testing.
    • Both diseases highlight the need for robust policies on result access and protection.

    Conclusions:

    • Ethical frameworks for genetic testing must address both known and unknown genetic conditions.
    • Protecting genetic information and managing psychological impact are paramount.
    • Balancing patient autonomy with potential psychological distress is key in genetic counseling.